Natural killer cell immunotypes related to COVID-19 disease severity
Science Immunology, 2020
Maucourant C., Filipovic I., Ponzetta A., Aleman S., Cornillet M., Hertwig L., Strunz B., Lentini A., Reinius B., Brownlie D., Cuapio A., Ask E., Hull R., Haroun-Izquierdo A., Schaffer M., Klingström J., Folkesson E., Buggert M., Sandberg J., Eriksson L., Rooyackers O., Ljunggren H., Malmberg K., Michaëlsson J., Marquardt N., Hammer Q., Strålin K., Björkström N.,
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
Infectious Diseases | Pathophysiology | Serum |  Olink Target 96 |
Abstract
The NK cell activation landscape in acute SARS-CoV-2 infection is associated with COVID-19 disease severity.